{
    "name": "anti-inhibitor coagulant complex",
    "comment": "Rx",
    "other_names": [
        "Feiba NF",
        "Feiba VH Immuno"
    ],
    "classes": [
        "Coagulation Factors",
        "Hemostatics"
    ],
    "source": "https://reference.medscape.com/drug/feiba-vh-immuno-anti-inhibitor-coagulant-complex-342103",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: Not studied"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Not studied"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "Thrombotic and thromboembolic events have been reported during post-marketing surveillance following infusion, particularly following the administration of high doses and/or in patients with thrombotic risk factors"
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Treatment of bleeding occurrences resulting from deficiencies in coagulation factors VIII or IX",
                "DIC",
                "Normal coagulation mechanisms present"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Neonates (risk of thrombosis and/or hepatitis)",
                "Risk of transmissible infectious disease from human plasma (rare)",
                "Possibility of transient hypofibrinogenemia in children",
                "Administer to pregnant patients only if benefits outweigh risks",
                "Caution in patients with hepatic impairment",
                "Small amounts of factor VIII in the formulation may cause an anamnestic response",
                "Avoid or delay use in patients receiving treatment with antifibrolytic agents",
                "Only use to control bleeding in patients with coagulation deficiencies",
                "Discontinue in case of severe hypersensitivity reactions"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Contraindicated",
            "interaction_with": "prothrombin complex concentrate, human",
            "description": {
                "common": "anti-inhibitor coagulant complex increases effects of prothrombin complex concentrate, human by pharmacodynamic synergism. Contraindicated. Coadministration increases risk of thrombosis."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "tranexamic acid injection",
            "description": {
                "common": "anti-inhibitor coagulant complex, tranexamic acid injection.\nEither increases toxicity of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Coadministration ma."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "tranexamic acid oral",
            "description": {
                "common": "tranexamic acid oral, anti-inhibitor coagulant complex.\nEither increases toxicity of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Coadministration may increase risk for thrombosis."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Lethargy",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Chest discomfort",
            "percent": null
        },
        {
            "name": "Chills",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Injection site pain",
            "percent": null
        },
        {
            "name": "Fever",
            "percent": null
        },
        {
            "name": "Flushing",
            "percent": null
        },
        {
            "name": "Hypotension",
            "percent": null
        },
        {
            "name": "Myocardial infarction",
            "percent": null
        },
        {
            "name": "Tachycardia",
            "percent": null
        },
        {
            "name": "Thromboembolic events",
            "percent": null
        },
        {
            "name": "Hypersensitivity reactions",
            "percent": null
        }
    ]
}